• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    GeneDx Holdings Corp. - Class A Common Stock (NQ: WGS )

    77.74 -3.95 (-4.84%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Nov 1, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about GeneDx Holdings Corp. - Class A Common Stock

    < Previous 1 2 3 4 5 Next >
    Gold Gains 1%; Phillips 66 Shares Fall After Q3 Results
    Via Benzinga
    Nasdaq Surges Over 100 Points; Pfizer Earnings Top Views
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's Intraday Session
    Via Benzinga
    Genetic Testing Firm GeneDx Reports Narrower Q3 Loss As Revenues Surge, Lifts Annual Guidance
    GeneDx stock rises as Q3 results beat expectations with EPS loss improvement, 44% revenue growth to $76.87M, and 77% increase in test revenue. 
    Via Benzinga
    Corning Posts Upbeat Q3 Earnings, Joins Opera, Inari Medical, Incyte And Other Big Stocks Moving Higher On Tuesday
    Via Benzinga
    The Analyst Verdict: GeneDx Hldgs In The Eyes Of 6 Experts
    Via Benzinga
    GeneDx Stock Rocketed 1310% In Dramatic Turnaround Powered By DNA Analytics
    The company provides sequencing tools to help diagnose children with rare diseases. 
    Via Investor's Business Daily
    GeneDx Reports Third Quarter 2024 Financial Results and Business Highlights
    From GeneDx
    Via Business Wire
    Groundbreaking GUARDIAN Study Shows Benefits of Adding Genome Sequencing to Newborn Screening; Augments and Improves Standard Newborn Screening
    From GeneDx
    Via Business Wire
    GeneDx to Showcase Data from Largest Genomic Newborn Screening Cohort of 14,000 Newborns
    From GeneDx
    Via Business Wire
    Expert Ratings For GeneDx Hldgs
    Via Benzinga
    The Latest Analyst Ratings For GeneDx Hldgs
    Via Benzinga
    GeneDx to Report Third Quarter 2024 Financial Results on Tuesday, October 29, 2024
    From GeneDx
    Via Business Wire
    The Markets Are Ignoring Risk, But That Does Not Mean You Should...
    It is Fall clean-up time. Sell lagging and sagging companies. 
    Via Talk Markets
    GeneDx Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From GeneDx
    Via Business Wire
    GeneDx to Participate in Fall Investor Conferences
    From GeneDx
    Via Business Wire
    GeneDx Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From GeneDx
    Via Business Wire
    WGS Stock Earnings: GeneDx Hldgs Beats EPS, Beats Revenue for Q2 2024
    WGS stock results show that GeneDx Hldgs beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. 
    Via InvestorPlace
    GeneDx Announces Whole Genome Sequencing (WGS) Product Enhancements to Accelerate Diagnoses for More Patients
    From GeneDx
    Via Business Wire
    GeneDx Reports Second Quarter 2024 Financial Results and Business Highlights
    From GeneDx
    Via Business Wire
    GeneDx Leads Russell 2000 This Year As It Shifts To More Comprehensive Genetic Testing
    GeneDx Holdings Corp. (NASDAQ: WGS) has soared 1,101% this year, attributed to its mix shift towards exome/genome testing and record high margins. 
    Via Benzinga
    GeneDx to Report Second Quarter 2024 Financial Results on Tuesday, July 30, 2024
    From GeneDx Holdings Corp.
    Via GlobeNewswire
    7 Small-Cap Stocks With Massive Potential Returns
    Explore these small-cap stocks with high potential in health care, REITs, entertainment, hardware, finance, and distribution industries. 
    Via InvestorPlace
    GeneDx Announces Collaboration with Epic Aura to Expand Access to Rapid Whole Genome Sequencing (rWGS) Services to Inform Diagnosis in Affected Pediatric and Neonatal Patients
    From GeneDx Holdings Corp.
    Via GlobeNewswire
    Over $12M Bet On PBF Energy? Check Out These 3 Stocks Insiders Are Buying
    Via Benzinga
    GeneDx Announces Patient Access Program to Expand Access to Exome Testing for Pediatric Epilepsy Patients
    From GeneDx Holdings Corp.
    Via GlobeNewswire
    Over $4M Bet On ProFrac Holding? Check Out These 3 Stocks Insiders Are Buying
    Via Benzinga
    GeneDx to Participate in Upcoming Investor Conferences
    From GeneDx Holdings Corp.
    Via GlobeNewswire
    Over $1M Bet On This Healthcare Stock? Check Out These 3 Stocks Insiders Are Buying
    Via Benzinga
    Gold Down Over 2%; 3M Profit Beats Expectations
    Via Benzinga
    < Previous 1 2 3 4 5 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.